Thyrocare invites analysts to a conference call on May 7, 2026, to discuss audited Q4 and FY26 results.
The call, arranged under SEBI Listing Regulation 30, will feature the Chairman, MD, CEO, CFO, and other senior management.
Dial-in details and a webcast link are provided for access to the management discussion.